silybin has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Li, X; Shi, Q; Zhang, J | 1 |
| Li, TL; Tao, ZS; Wang, HS; Wei, S | 1 |
| Du, Q; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, P; Liu, W; Ma, K; Mizuno, K; Wu, X | 1 |
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Liu, B; Liu, P; Liu, W; Mizuno, K; Onodera, S; Ushiki-Kaku, Y | 1 |
| Çelik, DA; Özçelik, N; Sevimli, M; Sevimli, TS; Toğay, VA | 1 |
| Auddy, RG; Chakraborti, AS; Das, S; Mukherjee, A; Pal, R; Roy, P | 1 |
| Baskota, A; Chen, YX; Shi, K; Tian, HM; Zhang, HT; Zhou, FL | 1 |
| Cai, L; Chen, H; Lu, D; Wang, Q; Wang, T; Wang, Y; Ying, X | 1 |
8 other study(ies) available for silybin and Alloxan Diabetes
| Article | Year |
|---|---|
Silibinin augments the effect of clopidogrel on atherosclerosis in diabetic ApoE deficiency mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Clopidogrel; Diabetes Mellitus, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Silybin | 2022 |
Silibinin-modified Hydroxyapatite coating promotes the osseointegration of titanium rods by activation SIRT1/SOD2 signaling pathway in diabetic rats.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Experimental; Durapatite; Hyperglycemia; Osseointegration; Osteoblasts; Osteogenesis; Rats; Reactive Oxygen Species; Signal Transduction; Silybin; Sirtuin 1; Superoxide Dismutase; Titanium | 2022 |
Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ferroptosis; Glucose; Mitophagy; Palmitic Acid; Protein Kinases; Rats; Reactive Oxygen Species; Silybin; Ubiquitin-Protein Ligases | 2023 |
Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Topics: Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hippocampus; Insulin; Insulin-Like Growth Factor I; Male; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Rats; Signal Transduction; Silybin; Streptozocin; tau Proteins | 2020 |
DNA damage in rats with streptozotocin-induced diabetes; protective effect of silibinin.
Topics: Animals; Body Weight; Case-Control Studies; Comet Assay; Diabetes Mellitus, Experimental; DNA Damage; Male; Rats; Silybin | 2018 |
Engineered silybin nanoparticles educe efficient control in experimental diabetes.
Topics: Animals; Biocompatible Materials; Blood Glucose; Chitosan; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Liver; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Silybin; Silymarin; Streptozocin | 2014 |
Silybin reduces obliterated retinal capillaries in experimental diabetic retinopathy in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Count; Leukostasis; Male; Rats, Sprague-Dawley; Retinal Vessels; Silybin; Silymarin | 2014 |
The protective effects of silibinin in the treatment of streptozotocin-induced diabetic osteoporosis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Experimental; Female; Femur; Osteogenesis; Osteoporosis; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Silybin; Silymarin; Trabecular Meshwork | 2017 |